Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof: Institution of Investigation Pursuant to 19 U.S.C. 1337
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 28, 2013, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of ResMed Corporation of San Diego, California; ResMed Incorporated of San Diego, California; and ResMed Limited of Australia. A letter supplementing the Complaint was filed on April 19, 2013. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain sleep-disordered breathing treatment systems and components thereof by reason of infringement of certain claims of U.S. Patent No. 6,216,691 (``the '691 patent''), U.S. Patent No. 6,935,337 (``the '337 patent''), U.S. Patent No. 7,159,587 (``the '587 patent''), U.S. Patent No. 7,487,772 (``the '772 patent''), U.S. Patent No. 7,614,398 (``the '398 patent''), U.S. Patent No. 7,743,767 (``the '767 patent''), and U.S. Patent No. 7,997,267 (``the '267 patent''). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainants request that the Commission institute an investigation and, after the investigation, issue an exclusion order and cease and desist orders.